Contact Sessions
James Skelley | Technology Lawyer
SESSIONS
Sessions are online meetups for discussing recent legal news, general education, and sharing various of James' research. The next scheduled session is:


You can find a complete listing of upcoming sessions and request to join HERE.
(Informal 1-2 line summaries, which certainly should not be relied upon for legal or other research purposes)
RECENT CASE HIGHLIGHTS
    • CAFC precedentially affirms noninfringement based upon construction of the term "universal" for various spinal-fusion implant claims. Here, Appellant:
      "[A]rgues that the district court erred in its (1) conclusion that the preambles of claims 1 and 10 (which depends from claim 1) of the ’913 patent and claim 47 of the ’022 patent are limiting and (2) construction of the term “universal.” "
      Regarding 1), CAFC agrees with the DCT that . . .
      "[t]he preamble at issue furnishes essential meaning to the claim. The claim does not merely recite a gripper with a plurality of prongs and a screw guide. It recites one that is, as the district court explained, “capable of manipulating and inserting ‘a universal, intervertebral bone fusion spacer’ into a disc space” . . . The “Background of the Invention” section describes “[t]he present invention” as relating “to a unique universal bidirectional screw (BDS) system” (emphasis CAFC's) . . . We conclude that because the drafter “cho[se] to use both the preamble and the body to define the subject matter of the claimed invention, the invention so defined, and not some other, is the one the patent protects.” (emphasis in original)."
      Similarly, CAFC agrees with the analysis around 2):
      "“[U]niversal[ity]” is a fundamental characteristic of the claimed invention and thus, even if considered alone, we would conclude that it is limiting . . . Moskowitz argues that the district court’s construction incorrectly requires “a hypothetical one-size-fits-all intervertebral bone fusion spacer/bi-directional transvertebral screw fusion device to be suitable for implantation in every region of the spine for every patient” . . . We see no error in the district court’s construction. The district court pointed to the patents’ specifications, which provide for multiple uses in all three spinal regions . . . the patents unambiguously describe the device as being adaptable across spinal regions and usable with multiple surgical approaches. That adaptability makes the design “universal.”"
      Ergo, CAFC affirms en toto.
    • In this precedential trade secrets damages matter CAFC reverses and affirms in part. Regarding the former, CAFC interestingly confirms that trade secret damages may be based upon unjust enrichment regardless of licensing history:
      "Versata argues that under both the Defend Trade Secrets Act and Michigan Uniform Trade Secrets Act, it is allowed to pursue unjust enrichment damages as a matter of statutory right. We agree with Versata that it was entitled to pursue unjust enrichment damages; the district court legally erred when it precluded Versata from doing so . . . We . . . conclude that Versata may seek unjust enrichment damages under the DTSA and the MUTSA as a matter of law . . . The district court’s reliance in this case on precedent where the parties’ licensing history was used to calculate damages to categorically preclude recovery of unjust enrichment damages is misplaced."
      CAFC similarly reverses as to breach of contract damages, reviving the jury award:
      "Versata argues that the district court erred in reducing the jury award because it presented sufficient evidence for the jury to accurately calculate damages. We agree and conclude that the district court erred when it reduced the jury award from $82,260,000 to $3. Accordingly, we reverse the district court’s JMOL Decision and reinstate the jury award for breach of contract damages"
      As for the affirmance, CAFC agrees with the DCT that the specific combination of elements in the trade secret need not be identified:
      "Ford argues that “Versata offered insufficient evidence that Ford had knowledge of each alleged combination trade secret.” . . . That is, Ford claims that Versata provided no evidence that it identified the specific “bundles of features [Grid, Buildability, and Workspaces of the ACM software] to Ford” but instead provided hundreds of documents to Ford containing these trade secrets . . Therefore, because Versata failed to demonstrate that Ford had specific knowledge of the ACM combination trade secrets, Ford argues that the district court’s judgment on trade secret liability must be reversed. Neither the DTSA nor the MUTSA, however, requires a plaintiff to show a defendant’s knowledge of specific elements of combination trade secrets . . . Nothing in the language of either statute requires the degree of specific knowledge of the exact combination of a trade secret that Ford urges us to read in."
      Ergo, reversed in part and affirmed in part.
    • CAFC affirms attorney sanctions under 285 in this optics filters patent infringement matter. Basically, plaintiff understood defendant's filters met standards implying infringement, but only actually analyzed a no longer extant filter product:
      "[Defendant] asserted that summary judgment was warranted because Viavi’s infringement contentions identified only the 11246 Filter, which had been released of any pre-May 1, 2020 infringement and that had not been manufactured or sold since May 1, 2020 . . . [Plaintiff] opposed the summary judgment motion . . . It contended that the scope of the case went beyond the 11246 Filter, even as that was the only filter included in the claim charts accompanying Viavi’s complaint. Further, Viavi contended it was entitled to reasonable discovery from PTOT so that it could obtain information about any of PTOT’s filters that were incorporated into the major company’s devices."
      Here, plaintiff asserts that its pre-suit diligence was sufficient to avoid sanctions, but CAFC agrees with the DCT that the diligence focused on the "wrong" filter and that "a more thorough investigation would have prevented Viavi from invoking the 11246 Filter in its suit against PTOT".
      "In fact, as soon as Viavi finally purchased several of the major company’s devices, it discovered that the only non-Viavi filter being used in one of these devices was not the 11246 Filter . . . After learning this, Viavi even initiated a new action wherein it sued based only on Filter #25, not on the 11246 Filter. Therefore, Viavi’s own actions indicate that, with a more searching pre-suit investigation, it “would have not filed” the suit it ended up filing here."
      Ergo, after considering and rejecting other arguments involving the anticipated results of discovery, CAFC affirms.
    • This is a very brief, but important, claim construction reminder that while the analysis begins with the claim language itself, and while one should not unfairly import limitations into the claim, where "a patent ‘repeatedly and consistently’ characterizes a claim term in a particular way, it is proper to construe the claim term in accordance with that characterization." Accordingly, here, where the claims recite a pH range *between* X and Y, and the spec consistently spoke to *maintaining* that range during the process, CAFC agrees with a construction finding that a target maintaining the range for only 90% of the process did not infringe. Say it with me: "Context is king."
    • In this precedential IPR obviousness decision involving claims directed to "computer memory systems, and more specifically to “improving the performance and the memory capacity of . . . memory boards that include dual in-line memory modules”", CAFC affirms the Board's obviousness determination. Owner makes two arguments on appeal:

      1. "First, Netlist argues that the Board erred by determining that Ellsberry teaches data paths that are enabled “in accordance with a latency parameter,” as recited in limitation"; and
      2. "Second, Netlist argues the Board erred by determining that Ellsberry teaches “enabl[ing]” a “data path,” as recited by limitations [1e] and [1f]"

      As regards 1), CAFC finds substantial evidence in the record:
      "The Board’s reliance on Ellsberry’s teachings, as supported by the JEDEC standards, constitutes substantial evidence that Ellsberry teaches enabling data paths in accordance with a latency parameter."
      However . . .
      "Netlist further argues that, even if the Board had substantial evidence to find that Ellsberry uses latency information to control data paths, the Board erred by using the ’537 patent, which was not part of Samsung’s petition ground, to supply the missing limitation of enabling the data paths at the required time to account for the buffer . . . According to Netlist, the Board’s explanation shows that it impermissibly expanded the role of the ’537 patent from mere evidence of the general skill in the art to that of a prior art reference. This would violate the restriction that the Board may not depart from the petition and find claims invalid on grounds “of [its] own design."
      Alas, even if there was error, CAFC considers it harmless:
      "[A]ny potential error was harmless because the Board alternatively found that Ellsberry alone, without relying on the ’537 patent, teaches adding one clock cycle to account for propagation delay through its switch ASICs"
      As for 2):
      "Netlist argues this paragraph [of the Ellsberry reference] does not teach enabling the claimed “data path” because Ports A and B that it refers to are located outside of the switch ASIC (i.e., the claimed buffer) instead of within the switch ASIC, as required by the claims." (emphasis in the original)
      CAFC agrees with the Board that proferred evidence for this assertion is inadequate. Specifically, the labels "Port A" and "Port B" appear within the Switch ASIC of the prior art figure, which seems to agree with portions of the specification ("Ellsberry teaches that “memory bank switch 206 [the Switch ASIC] includes Port A and Port B").

      Ergo, after briefly considering some APA challenges, CAFC affirms.
More . . .
ABOUT
James Skelley is a solo practitioner based in Mountain View, California since 2015, focusing primarily upon technology transactions and intellectual property procurement. James' practice also serves as an "incubator" for new legal service technologies / methodologies and a "living example" of their application. To this end, James regularly partners with larger law firms and with his clients so as to improve the practice of intellectual property law.

LEGAL PRACTICE AREAS
  • Utility / Design / PCT Patent Prosecution
  • Open Source Diligence
  • Technology Transactions (typically as a team)
  • Litigation / Inter Partes Review Support (typically as a team)
  • James tends NOT to handle low-volume trademark work (though referrals are available)
LICENSING
  • USPTO - #59458 - 10/16/2006
  • California - #257829 - 12/01/2008
  • District Columbia - #1014986 - 08/05/2013
CONTACT
  • James is available by email, 8x8 hangout, and in-person meetups in the Valley.
  • Email is typically the best way to reach James.
TECHNICAL FIELDS
  • Machine Learning / Robotics
  • Cryptograpy / Cryptocurrency / Smart Contracts
  • Medical Device
  • Computational Biology (primarily modeling and proteomics)
  • Signal Processing (primarily wireless and compression)
  • Quantum Physics (primarily semiconductor) / Electromagnetics (antennae, waveguides, etc.)
  • Manufacturing / 3D Printing
  • James tends NOT to handle pure chemistry applications (though referrals are available), however James HAS handled matters involving computational proteomics, cellular modeling, and diagnostic lab protocols
SOFTWARE
LAWMUX BITES
LawMux Bites are (very) short, one-page summaries of various legal concepts, cases, and technologies. As informal summaries, you certainly shouldn't rely upon them as legal advice / for business use, but they can help orient you if you're new to the subject matter.

LAWMUX BITES
PAPERS / ARTICLES